Anticorps conjugués

anticorps conjugués, antibody-drug conjugates, ADCs, market analysis, analyse marché, anticorps conjugués, anticorps armés, monoclonal antibody conjugated, immunoconjugués

L’analyse marché MabDesign de ce mois-ci vous donne un aperçu du marché et des projets d’anticorps conjugués (antibody-drug conjugates) en développement.

Monoclonal antibodies: the stars of therapeutic proteins

mAbs, anticorps monoclonal monoclonaux

Hybridoma technology for the production of monoclonal antibodies (mAbs), awarded the Nobel Prize for Medicine in 1984, revolutionized serotherapy, which previously used patient serum containing mixtures of antibodies. More targeted and therefore more effective, mAbs offer innovative perspectives in the treatment of various diseases, and have become an essential therapeutic strategy in our pharmaceutical arsenal.